You might notice your appetite feels a little stronger at first, this is normal and should settle as your treatment is adjusted
In August 2025 , Wegovy became the first GLP-1 therapy approved to treat non-cirrhotic MASH (liver disease)
Whatsapp 300 889 66 48, lnea directa llamadas y chat.
Florida: The Most Restrictive Floridas Board of Medicine has detailed rules (64B15-14.004) for prescribing anti-obesity medications: Required before prescribing : BMI 30, or 27 with comorbidity (documented in chart) Comprehensive history and physical exam (can be delegated to an APRN but must meet standard of care) Lab workup to rule out secondary causes of obesity (thyroid, glucose, etc.) Written informed consent from the patient Provision of the states Weight-Loss Consumer Bill of Rights brochure Ongoing requirements : Face-to-face follow-up every 3 months minimum (can be via telehealth) Document weight, vital signs, and medication tolerance at each visit Chart must justify continued use of medication Telehealth restrictions : Florida prohibits prescribing controlled substances via telehealth except for psychiatric treatment, inpatient/hospice care, or emergency addiction treatment This means phentermine (Schedule IV) cannot be prescribed via pure telehealth for weight loss in Florida unless theres a co-occurring psychiatric diagnosis (and even then, tread carefully) GLP-1 agonists are NOT controlled and can be prescribed via telehealth if standard of care is met Bottom line : If youre seeing Florida patients via telehealth for weight loss, stick to non-controlled medications (GLP-1s, orlistat, etc.) or ensure an in-person component for controlled substances
